<div id="readability-page-1">Eikon Therapeutics, Inc (NASDAQ:EIKN) IPO will take place February, 05 on the NASDAQ exchange under the ticker EIKN. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on August 04, 2026. See also: Benzinga IPO Calendar <h3>About Eikon Therapeutics, Inc</h3> Eikon Therapeutics, Inc is a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing important, innovative medicines to address serious unmet medical needs. See also: Benzinga's Most Shorted Stocks This article was generated by Benzinga's automated content engine and reviewed by an editor.</div>

2 倍做多納斯達克生物技術 ETF - ProShares

標普生物技術 ETF - SPDR

醫藥突破 ETF - ALPS

紐交所高增長板生物技術指數 ETF - First Trust

生物科技 ETF - VanEck Vectors

納斯達克生物科技指數 ETF - iShares Nasdaq

阿尼卡醫療

NBSE.ESC

動態生物技術與基因組 ETF - Invesco

Eikon Therapeutics, Inc 將於 2026 年 2 月 5 日在納斯達克上市，股票代碼為 EIKN。預計每股價格在 16.00 美元至 18.00 美元之間，內部鎖定期為 180 天，將於 2026 年 8 月 4 日結束。該公司專注於開發針對嚴重未滿足醫療需求的創新藥物

Preview: Eikon Therapeutics, Inc Set To IPO Tomorrow

fidelity

ESC NEUBASE THERAPEUTI

預覽：Eikon Therapeutics, Inc 將於明日進行首次公開募股